Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Immunohistochemical Analysis of Inflammatory Rheumatoid Synovial Tissues Using Anti-Human Podoplanin Monoclonal Antibody Panel.

Suzuki T, Takakubo Y, Oki H, Liu X, Honma R, Naganuma Y, Goodman SB, Kaneko MK, Kato Y, Takagi M.

Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):12-19. doi: 10.1089/mab.2017.0047. Epub 2018 Jan 29.

PMID:
29377768
2.

Establishment of Novel Monoclonal Antibody PMab-32 Against Rabbit Podoplanin.

Honma R, Fujii Y, Ogasawara S, Oki H, Liu X, Nakamura T, Kaneko MK, Takagi M, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2016 Feb;35(1):41-7. doi: 10.1089/mab.2015.0066. Epub 2016 Jan 20.

PMID:
26788987
3.

Development of Sensitive Monoclonal Antibody PMab-2 Against Rat Podoplanin.

Oki H, Honma R, Ogasawara S, Fujii Y, Liu X, Takagi M, Kaneko MK, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2015 Dec;34(6):396-403. doi: 10.1089/mab.2015.0041.

PMID:
26683179
4.

Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.

Ogasawara S, Oki H, Kaneko MK, Hozumi Y, Liu X, Honma R, Fujii Y, Nakamura T, Goto K, Takagi M, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2015 Oct;34(5):318-26. doi: 10.1089/mab.2015.0018.

PMID:
26492619
5.

Monoclonal Antibody LpMab-9 Recognizes O-glycosylated N-Terminus of Human Podoplanin.

Kaneko MK, Oki H, Hozumi Y, Liu X, Ogasawara S, Takagi M, Goto K, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2015 Oct;34(5):310-7. doi: 10.1089/mab.2015.0022.

PMID:
26492618
6.

A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas.

Fujii Y, Ogasawara S, Oki H, Liu X, Kaneko MK, Takano S, Kato Y.

Biochem Biophys Res Commun. 2015 Oct 30;466(4):733-9. doi: 10.1016/j.bbrc.2015.09.070. Epub 2015 Sep 14.

PMID:
26381180
7.

Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin.

Oki H, Kaneko MK, Ogasawara S, Tsujimoto Y, Liu X, Sugawara M, Takakubo Y, Takagi M, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2015 Jun;34(3):174-80. doi: 10.1089/mab.2014.0090.

PMID:
26090595
8.

A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.

Liu X, Ogasawara S, Kaneko MK, Oki H, Hozumi Y, Goto K, Takagi M, Kato Y.

Biochem Biophys Res Commun. 2015 Apr 17;459(4):636-42. doi: 10.1016/j.bbrc.2015.02.162. Epub 2015 Mar 6.

PMID:
25753205
9.

Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas.

Takano S, Kato Y, Yamamoto T, Liu X, Ishikawa E, Kaneko MK, Ogasawara S, Matsuda M, Noguchi M, Matsumura A.

Brain Tumor Pathol. 2015 Jul;32(3):169-75. doi: 10.1007/s10014-015-0214-8. Epub 2015 Feb 5.

PMID:
25652153
10.

Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone.

Kato Kaneko M, Liu X, Oki H, Ogasawara S, Nakamura T, Saidoh N, Tsujimoto Y, Matsuyama Y, Uruno A, Sugawara M, Tsuchiya T, Yamakawa M, Yamamoto M, Takagi M, Kato Y.

Cancer Sci. 2014 Jun;105(6):744-8. doi: 10.1111/cas.12413.

11.

Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1.

Liu X, Kato Y, Kaneko MK, Sugawara M, Ogasawara S, Tsujimoto Y, Naganuma Y, Yamakawa M, Tsuchiya T, Takagi M.

Cancer Med. 2013 Dec;2(6):803-14. doi: 10.1002/cam4.149. Epub 2013 Oct 17.

12.

IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.

Moriya K, Kaneko MK, Liu X, Hosaka M, Fujishima F, Sakuma J, Ogasawara S, Watanabe M, Sasahara Y, Kure S, Kato Y.

Cancer Sci. 2014 Mar;105(3):359-62. doi: 10.1111/cas.12337.

13.

Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations.

Ogasawara S, Kaneko MK, Tsujimoto Y, Liu X, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2013 Dec;32(6):377-81. doi: 10.1089/mab.2013.0050.

PMID:
24328739

Supplemental Content

Loading ...
Support Center